Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Cash from Investing Activities: 2017-2024

Historic Cash from Investing Activities for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to -$1.2 million.

  • Bicycle Therapeutics' Cash from Investing Activities fell 54.94% to -$674,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 133.55%. This contributed to the annual value of -$1.2 million for FY2024, which is 57.84% up from last year.
  • As of FY2024, Bicycle Therapeutics' Cash from Investing Activities stood at -$1.2 million, which was up 57.84% from -$2.9 million recorded in FY2023.
  • In the past 5 years, Bicycle Therapeutics' Cash from Investing Activities registered a high of -$1.2 million during FY2020, and its lowest value of -$19.0 million during FY2022.
  • Over the past 3 years, Bicycle Therapeutics' median Cash from Investing Activities value was -$2.9 million (recorded in 2023), while the average stood at -$7.7 million.
  • Per our database at Business Quant, Bicycle Therapeutics' Cash from Investing Activities crashed by 835.32% in 2022 and then surged by 84.57% in 2023.
  • Bicycle Therapeutics' Cash from Investing Activities (Yearly) stood at -$1.2 million in 2020, then plummeted by 69.17% to -$2.0 million in 2021, then slumped by 835.32% to -$19.0 million in 2022, then surged by 84.57% to -$2.9 million in 2023, then spiked by 57.84% to -$1.2 million in 2024.